Role of oncoprotein Growth Factor Independent-1 (GFI1) in repression of 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1): A comparative analysis in human prostate cancer and kidney cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 3-5, 2007, Pages 742-746

  Dwivedi, Prem P ^a   Anderson, Paul H ^a   Tilley, Wayne D ^a   May, Brian K ^b   Morris, Howard A ^a  

^a HANSON INSTITUTE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

1,25 Dihydroxyvitamin D (1,25D); 25 Hydroxyvitamin D (25D); 25 Hydroxyvitamin D 1alpha hydroxylase (CYP27B1); Growth Factor Independent 1 (GFI1); Renilla luciferase (RL); Thymidine kinase (TK)

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; GROWTH FACTOR INDEPENDENT 1; HISTONE DEACETYLASE; ONCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; COMPARATIVE STUDY; CONTROLLED STUDY; DEFENSE MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CELL; MALE; PROSTATE CANCER;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; 5' FLANKING REGION; BINDING SITES; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; MALE; MUTATION; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS;

RENILLA LUCIFERASE;

EID: 33947118187     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.12.014     Document Type: Article

References (14)

1. Omdahl J.L., Morris H.A., and May B.K. Hydroxylase enzymes of the Vitamin D pathway: expression, function, and regulation. Annu. Rev. Nutr. 22 (2002) 139-166
2. Omdahl J.L., Bobrovnikova E.A., Choe S., Dwivedi P.P., and May B.K. Overview of regulatory cytochrome P450 enzymes of the Vitamin D pathway. Steroids 66 (2001) 381-389
3. Anderson P.H., May B.K., and Morris H.A. Vitamin D metabolism: new concepts and clinical implications. Clin. Biochem. Rev. 24 (2003) 13-26
4. Dwivedi P.P., Omdahl J.L., Kola I., Hume D.A., and May B.K. Regulation of rat cytochrome P450C24 (CYP24) gene expression: evidence for functional cooperation of Ras-activated Ets transcription factors with the Vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction. J. Biol. Chem. 275 (2000) 47-55
5. Dwivedi P.P., Hii C.S.T., Ferrante A., Tan J., Der C.J., Omdahl J.L., Morris H.A., and May B.K. Role of MAP kinases in the 1,25-dihydroxyvitamin D3-induced transactivation of the rat cytochrome P450c24 (CYP24) promoter: specific functions for ERK1/ERK2 and ERK5. J. Biol. Chem. 277 (2002) 29643-29653
6. Nutchey B.K., Kaplan J.K., Dwivedi P.P., Omdahl J.L., Ferrante A., May B.K., and Hii C.S.T. Molecular action of 1,25-dihydroxyvitamin D3 and phorbol ester on the activation of the rat cytochrome P450C24 (CYP24) promoter: role of MAP kinase activities and identification of an important transcription factor binding site. Biochem. J. 389 (2005) 753-762
7. Hsu J.Y., Feldman D., McNeal J.E., and Peehl D.M. Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition. Cancer Res. 61 (2001) 2852-2856
8. Dwivedi P.P., Anderson P.H., Omdahl J.L., Grimes H.L., Morris H.A., and May B.K. Identification of Growth Factor Independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cells. Endocr. Relat. Cancer 12 (2005) 351-365
9. Gao X.H., Dwivedi P.P., Choe S., Alba F., Morris H.A., Omdahl J.L., and May B.K. Basal and parathyroid hormone induced expression of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene promoter in kidney AOK-B50 cells: role of Sp1, Ets and CCAAT box protein binding sites. Int. J. Biochem. Cell Biol. 34 (2002) 921-930
10. McGhee L., Bryan J., Elliott L., Grimes H.L., Kazanjian A., Davis J.N., and Meyers S. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism. J. Cell. Biochem. 89 (2003) 1005-1018
11. Peehl D.M., and Feldman D. The role of Vitamin D and retinoids in controlling prostate cancer progression. Endocr. Relat. Cancer 10 (2003) 131-140
12. Garland C.F., Garland F.C., Gorham E.D., Lipkin M., Newmark H., Mohr S.B., and Holick S.B.M.F. The role of Vitamin D in cancer prevention. Am. J. Public Health 96 (2006) 252-261
13. Chen T.C., Wang L., Whitlatch L.W., Flanagan J.N., and Holick M.F. Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. J. Cell. Biochem. 88 (2003) 315-322
14. Oettgen P., Finger E., Sun Z., Akbarali Y., Thamrongsak U., Boltax J., Grall F., Dube A., Weiss A., Brown L., Quinn G., Kas G.K., Endress G., Kunsch C., and Libermann T.A. PDEF, a novel prostate epithelium-specific Ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression. J. Biol. Chem. 275 (2000) 1216-1225